Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 392 of 6351
-
Could a peptide supplement supercharge muscle gains from weightlifting?
Disease control Recruiting nowSkeletal muscle size, an important metabolic tissue, is governed by the balance between two opposing processes, muscle protein synthesis and muscle protein breakdown. In response to long-term resistance exercise (weightlifting), skeletal muscle growth is commonly observed and it …
Sponsor: University of Birmingham • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
New heart pump could save lives after surgery shock
Disease control Recruiting nowThis study is a prospective, multicenter, single-arm clinical trial conducted in China to evaluate the efficacy and safety of a novel left ventricular assist device, SynFlow Duro system, manufactured by ForQaly Medical in the treatment of post cardiotomy cardiogenic shock.
Sponsor: ForQaly Medical (Shanghai) Co., Ltd • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can early tumor response guide smarter cancer treatment?
Disease control Not yet recruitingEsophageal squamous cell carcinoma (ESCC) is a common and aggressive malignancy with poor prognosis, particularly in patients with locally advanced disease. Neoadjuvant chemoimmunotherapy has shown promising antitumor activity and may improve pathological response; however, a pro…
Phase 2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New pill shows promise for Hard-to-Treat blood cancer
Disease control Recruiting nowThe goal of this clinical trial is to evaluate the efficacy and safety of Lacutoclax, an oral selective BCL-2 inhibitor, in patients with relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL). Lacutoclax is a potent and selective BCL-2 inhibitor…
Phase 2 • Sponsor: Guangzhou Lupeng Pharmaceutical Company LTD. • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Could fewer pills mean same relief for rheumatoid arthritis?
Disease control Recruiting nowThe goal is to investigate whether a strategy of attempting to discontinue of MTX or LEF (and restart when necessary) in RA patients treated with an optimal dose (allowed dose or lower, tapered to the maximum, or according to patient preference) TNFi is not worser to a continuati…
Phase 4 • Sponsor: Sint Maartenskliniek • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Can a Weight-Loss drug ease rett syndrome?
Symptom relief Recruiting nowThe purpose of this study is to investigate the efficacy of fenfluramine hydrochloride (HCl) versus placebo in study participants with Rett syndrome (RTT).
Phase 3 • Sponsor: UCB BIOSCIENCES, Inc. • Aim: Symptom relief
Last updated Aug 19, 2026 00:00 UTC
-
Double-Drug attack: new combo aims to tackle tough lung cancer
Disease control Not yet recruitingThis is a single-arm clinical study evaluating the safety, tolerability, and preliminary efficacy of JS212 in combination with JS111 as first-line treatment in participants with epidermal growth factor receptor (EGFR)-mutant locally advanced or metastatic non-small cell lung canc…
Sponsor: Huan Zhou • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Could a targeted antibody outdo steroids for a rare kidney disease?
Disease control Recruiting nowOBELIX-NEPHROSIS (NS) The goal of this clinical trial is to learn if obinutuzumab works to treat minimal change disease in adults. It will also learn about the safety of drug obinutuzumab. The main questions it aims to answer are: Is obinutuzumab non-inferior to glucocorticoids…
Phase 2 • Sponsor: Medical University Innsbruck • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
New combo therapy aims to tame leukemia without lifelong pills
Disease control Recruiting nowThe goal of this clinical research study is to find out if treatment with a combination of dasatinib plus ropeginterferon can help to control CML-CP. The safety of this combination will also be studied.
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
New drug shows promise for severe eczema in toddlers
Disease control Recruiting nowThe primary objective of the study is to assess the pharmacokinetics (PK) and safety of nemolizumab in pediatric participants (aged 6-23 months) with moderate-to-severe atopic dermatitis (AD) who are not adequately controlled with topical treatments.
Phase 2 • Sponsor: Galderma R&D • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Drug duo aims to tackle high blood pressure in obesity
Disease control Not yet recruitingThe EFFORT Study (Empagliflozin and Finerenone Combination in Obesity with Hypertension) is a 12-week, randomized, double-blind, placebo-controlled trial that aims to test whether combining empagliflozin (10 mg/day) with finerenone (10 mg/day, up-titrated to 20 mg after 4 weeks) …
Sponsor: Heart Health Research Center • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Brain pacemaker tamed violent outbursts in first human test
Disease control Not yet recruitingPhysical aggression can be defined as the use of force with the intention of causing physical injury, psychological damage or death. Pathological aggression may be associated with various psychiatric disorders. This symptom can often be improved by prescribing medication, impleme…
Sponsor: University Hospital, Rouen • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Touch and tingle: Non-Drug therapies aim to tame chemo side effects
Symptom relief Recruiting nowHead and neck cancer (HNC) patients undergoing concurrent chemoradiotherapy (CCRT) frequently experience pain, xerostomia, fatigue, sleep disturbance, and other treatment-related toxicities that impair quality of life and treatment adherence, with incomplete relief from current s…
Sponsor: Tzu Chi University • Aim: Symptom relief
Last updated Jul 26, 2026 00:00 UTC
-
Can a new drug combo slow advanced prostate cancer?
Disease control Not yet recruitingPhase Ib A preliminary design of 2 cohorts is planned for this phase, with 3-6 participants to be enrolled in each cohort. A total of 6-12 participants with advanced prostate cancer are planned to be enrolled in this phase. The study will be conducted at multiple investigational …
Phase 2 • Sponsor: Evopoint Biosciences Inc. • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Can we predict lung failure in children by measuring their breathing effort?
Knowledge-focused Recruiting nowPediatric acute respiratory distress syndrome (ARDS) is a life-threatening clinical syndrome, and dyspnea is its key symptom. Strenuous respiratory effort is a "second hit" for ARDS lungs, inducing changes in regional lung aeration and amplifying lung damage in preclinical studie…
Sponsor: Universidad Nacional Andres Bello • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
Could skipping some neck radiation spare patients side effects?
Disease control Recruiting nowThe goal of this clinical trial is to learn if selectively omitting postoperative cervical irradiation is a safe and feasible treatment strategy for patients with resected, locally advanced squamous cell carcinoma of the head and neck (HNSCC) who underwent systematic neck dissect…
Phase 2 • Sponsor: Institut Català d'Oncologia • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
New oral pill H021 aims to tame Crohn's Flare-Ups
Disease control Not yet recruitingThis study employs a multicenter, randomized, double-blind, placebo-controlled, parallel-group, continuous treatment design to evaluate the efficacy, safety, PPK characteristics, and PD effects of H021 Enteric-coated Tablets during both the induction and maintenance treatment per…
Phase 2 • Sponsor: Jiangsu Carephar Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
A simple blood draw could spare kids with leukemia from painful bone marrow tests
Knowledge-focused Not yet recruitingThis retrospective-prospective observational cohort study aims to evaluate peripheral blood plasma circulating tumor DNA (ctDNA) dynamics in pediatric acute leukemia and compare ctDNA results with concurrent bone marrow multiparameter flow cytometry minimal residual disease (MFC-…
Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Knowledge-focused
Last updated Aug 09, 2026 00:00 UTC
-
New inhaled therapy aims to improve breathing in COPD patients
Disease control Not yet recruitingThe purpose of this study is to evaluate the efficacy and safety of HSK39004 Inhalation Suspension in patients with moderate to severe Chronic Obstructive Pulmonary Disease (COPD).
Phase 3 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Non-Invasive combo therapy aims to restore bladder function in spinal cord injury
Disease control Not yet recruitingThis clinical trial aims to investigate whether the combination of high-frequency sacral nerve root magnetic stimulation and bladder-directed ultrasound therapy can effectively improve detrusor overactivity (involuntary bladder contractions) and related voiding dysfunctions in pa…
Sponsor: Shengjing Hospital • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC